Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

Summary

FACILITATE-HF is a multicenter, randomized, double-blind, placebo-controlled trial designed to determine whether initiation of finerenone during the early phase of hospitalization has beneficial effects in patients with AHF who have left ventricular ejection fraction 40% or more.

Timeline

Start

2026-02

Primary completion

2027-12

Completion

2028-09-30

Drugs

Indications